4,10,11,34 Patient considerations include assessing stabilization of comorbidities, such as diabetes and renal dysfunction, which may prolong drug clearance, as post-treatment bleeding events and slower wound healing are more likely
"Only three small human studies of BPC-157 exist, for instance, the largest of which is a telephone survey of 16 people who received an injection of the drug for knee pain, and which was published in a third-tier journal, Alternative Therapies." I am not sure what is being discussed here
Our recommendation: A 31G, 5/16" (8mm) needle is a fantastic starting point and a widely accepted standard for this type of research
If you get it into the muscle, it wont be as effective